CARMEN CORONA ZAVALA: Open Payments
NPI 1245915834 · AVON PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 91 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $308 · 2025 $1,866
Food & beverage: $1,608Education: $258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $322 |
| Janssen Biotech, Inc. | 9 | $249 |
| UCB, Inc. | 14 | $246 |
| E.R. Squibb & Sons, L.L.C. | 10 | $187 |
| Amgen Inc. | 12 | $173 |
| GENZYME CORPORATION | 5 | $130 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| PFIZER INC. | 4 | $71 |
Products named: RINVOQ, TREMFYA, Bimzelx, KEVZARA, ORENCIA, Otezla, BENLYSTA, SAPHNELO.
Industry payments across FL — which companies pay providers there.
